Search Within

Filemon Dela Cruz

Formats
  1. Meeting Abstract (31)
  2. Journal Article (28)
  3. Editorial (2)
  4. Review (1)
Groups
  1. Pediatrics, Department of (62)
  2. Sarcoma Service (Pediatrics) (62)
  3. Center for Hematologic Malignancies (45)
  4. Tow Center for Developmental Oncology (TCDO) (43)
  5. Executive Committee, Center for Hematologic Malignancies (41)
  6. Stem Cell Transplantation and Cellular Therapy Service (41)

More Groups

People
  1. Andrew Kung (41)
  2. Daoqi You (16)
  3. Julia Glade Bender (16)
  4. Michael Ortiz (14)
  5. Emily Slotkin (13)
  6. Glorymar Ibanez Sanchez (12)

More People

Years
  1. 2025 (2)
  2. 2024 (8)
  3. 2023 (5)
  4. 2022 (16)
  5. 2021 (6)
  6. 2020 (9)

More Years

Publications
  1. Journal of Clinical Oncology (12)
  2. Cancer Research (10)
  3. Pediatric Blood and Cancer (8)
  4. Cancer Discovery (3)
  5. Nature Communications (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Association for Cancer Research (16)
  2. American Society of Clinical Oncology (12)
  3. Wiley Periodicals, Inc (8)
  4. Nature Publishing Group (7)
  5. Elsevier Inc. (3)
  6. Nature Research (3)

More Publishers

Results (62)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The addition of cycles of irinotecan/temozolomide (i/T) to cycles of vincristine, doxorubicin, cyclophosphamide (VDC) and cycles of ifosfamide, etoposide (IE) for the treatment of Ewing sarcoma (ES)
    Meeting Abstract

    Meyers, P. A.; Ambati, S. R.; Slotkin, E. K.; Dela Cruz, F.; Wexler, L. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors
    Meeting Abstract

    Marks, L. J.; Diolaiti, D.; Mundi, P. S.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Califano, A.; Kung, A.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multiparameter profiling of abscopal effect (AbE) in a pediatric fibrosarcoma with EML4-NTRK3 fusion
    Meeting Abstract

    Gartrell, R. D.; Sims, J. S.; Barton, S. M.; Kadenhe-Chiweshe, A.; Dela Cruz, F.; Turk, A. T.; Kung, A. L.; Bruce, J. N.; Saenger, Y. M.; Yamashiro, D. J.; more...
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Local drug activation: Making cytotoxics safer for local tumors
    Meeting Abstract

    Srinivasan, S.; Dela Cruz, F.; Kung, A.; Gaviria, E.; Miller, E.; Yee, N.; Royzen, M.; Mejia-Oneto, J.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • A recurrent novel MGA-NUTM1 fusion identifies a new subtype of high-grade spindle cell sarcoma
    Journal Article

    Diolaiti, D.; Dela Cruz, F. S.; Gundem, G.; Bouvier, N.; Boulad, M.; Zhang, Y.; Chou, A. J.; Dunkel, I. J.; Sanghvi, R.; Shah, M.; more...
    Cold Spring Harbor Molecular Case Studies (2018)

    Fulltext@MSK | Save
  • Preclinical effect of selinexor (KPT-330), a selective inhibitor of nuclear export, in pediatric rhabdoid tumors
    Meeting Abstract

    Marks, L.; Diolaiti, D.; Mundi, P.; Gaviria, E.; Rainey, A.; Dela Cruz, F.; Andrea, C.; Kung, A.
    Pediatric Blood and Cancer (2018)

    Fulltext@MSK | Save
  • A precision oncology approach to the pharmacological targeting of mechanistic dependencies in neuroendocrine tumors
    Journal Article

    Alvarez, M. J.; Subramaniam, P. S.; Tang, L. H.; Grunn, A.; Aburi, M.; Rieckhof, G.; Komissarova, E. V.; Hagan, E. A.; Bodei, L.; Clemons, P. A.; more...
    Nature Genetics (2018)

    Fulltext@MSK | Save
  • Recurrent EML4-NTRK3 fusions in infantile fibrosarcoma and congenital mesoblastic nephroma suggest a revised testing strategy
    Journal Article

    Church, A. J.; Calicchio, M. L.; Nardi, V.; Skalova, A.; Pinto, A.; Dillon, D. A.; Gomez-Fernandez, C. R.; Manoj, N.; Haimes, J. D.; Stahl, J. A.; more...
    Modern Pathology (2018)

    Fulltext@MSK | Save
  • Therapeutic targeting of PGBD5-induced DNA repair dependency in pediatric solid tumors
    Journal Article

    Henssen, A. G.; Reed, C.; Jiang, E.; Garcia, H. D.; Von Stebut, J.; MacArthur, I. C.; Hundsdoerfer, P.; Kim, J. H.; De Stanchina, E.; Kuwahara, Y.; more...
    Science Translational Medicine (2017)

    Fulltext@MSK | Save
  • Inhibition of Hsp90 suppresses PI3K/AKT/mTOR signaling and has antitumor activity in Burkitt lymphoma
    Journal Article

    Giulino-Roth, L.; van Besien, H. J.; Dalton, T.; Totonchy, J. E.; Rodina, A.; Taldone, T.; Bolaender, A.; Erdjument-Bromage, H.; Sadek, J.; Chadburn, A.; more...
    Molecular Cancer Therapeutics (2017)

    Fulltext@MSK | Save